DEUTSCHE BANK AG\
BankPosition in SRRK — Scholar Rock Holding Corp
CIK 948046
FRANKFURT AM MAIN, 2M
Position in SRRK
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$11,886,592
+$1,923,893 QoQ
Shares Held
241,794
+6.9% QoQ
Ownership
0.202%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 69.73084526497763.ToString("F0")%
Shared 0.ToString("F0")%
None 30.269154735022376.ToString("F0")%
Common Shares in SRRK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DEUTSCHE BANK AG\ holds $2,976,719,496 across 248 Biotechnology names. SRRK ranks #36 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,537,736 | $686,660,626 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
625,388 | $483,199,777 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
761,464 | $251,945,590 | |
| 4 | INCY |
Incyte Corp
|
1,264,195 | $118,986,027 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,453,303 | $117,684,942 | |
| 6 | ARGX |
Argenx SE
|
139,381 | $101,782,972 | |
| 7 | INSM |
INSMED Inc
|
562,474 | $91,975,745 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
306,111 | $61,115,059 |
All Filings in SRRK
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,886,592 | 241,794 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $9,962,699 | 226,168 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $7,343,205 | 197,186 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $6,090,397 | 171,948 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $5,784,523 | 179,923 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $7,995,828 | 185,003 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $318,733 | 39,792 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $248,908 | 29,881 | Shares | Defined | 2025-06-12 | |
| 2024-03-31 | $527,756 | 29,716 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $543,884 | 28,930 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $152,664 | 21,502 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $104,406 | 13,847 | Shares | Defined | 2023-08-14 | |
| 2022-06-30 | $13,295 | 2,422 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $243,439 | 18,886 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $478,715 | 19,272 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $619,685 | 18,767 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $557,248 | 19,282 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $2,908,187 | 57,406 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $8,441,599 | 173,946 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $224,007 | 12,663 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $210,670 | 11,569 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $75,456 | 6,231 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||